Bio Rad Laboratories Inc/ US0905722072 /
| 2024-04-19 10:10:00 PM | Chg. -1.29 | Volume | Bid2024-04-19 | Ask2024-04-19 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 279.73USD | -0.46% | 294,125 Turnover: 41.19 mill. |
265.80Bid Size: 200 | 294.00Ask Size: 100 | 6.55 bill.USD | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 499.3390 | 491.3710 | 490.9520 | 498.6120 | 529 | ||||||
| Intangible Assets | 145.5000 | 199.5000 | 253.9000 | 332.1000 | 320.5000 | ||||||
| Long-Term Investments | 4,638.2050 | 9,561.1400 | 14,387.0060 | 8,830.8920 | 7,698.0700 | ||||||
| Fixed Assets | 5,828.7450 | 10,832.7650 | 15,786.7120 | 10,343.7240 | 9,250.7700 | ||||||
| Inventories | 554.0070 | 622.2530 | 572.2390 | 719.3000 | 780.5000 | ||||||
| Accounts Receivable | 392.6720 | 419.4240 | 423.5370 | 494.6450 | 489.0170 | ||||||
| Cash and Cash Equivalents | 660.6720 | 662.2050 | 470.7830 | 434.2150 | 403.8150 | ||||||
| Current Assets | 2,180.1550 | 2,139.8350 | 1,989.0880 | 3,157.9760 | 3,048.3300 | ||||||
| Total Assets | 8,008.9000 | 12,972.6000 | 17,775.8000 | 13,501.7000 | 12,299.1000 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 107.0140 | 139.4510 | 141.9410 | 135.0410 | 144.6250 | ||||||
| Long-term debt | 13.6000 | 12.3000 | 10.5000 | 1,197.7160 | 1,199.0520 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 997.8000 | - | - | - | - | ||||||
| Liabilities | 2,253.8430 | 3,092.6600 | 4,108.6660 | 3,886.4480 | 3,557.9670 | ||||||
| Share Capital | .0020 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 5,755.0570 | 9,879.9400 | 13,667.1340 | 9,615.2520 | 8,741.1330 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 8,008.9000 | 12,972.6000 | 17,775.8000 | 13,501.7000 | 12,299.1000 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,311.6590 | 2,545.6260 | 2,922.5450 | 2,802.2490 | 2,671.2620 | ||||||
| Depreciation (total) | 134.2000 | - | - | - | - | ||||||
| Operating Result | 229.6610 | 410.9570 | 489.4300 | 482.6160 | 337.7960 | ||||||
| Interest Income | -23.4160 | -21.8610 | -1.5510 | -38.1140 | -49.4390 | ||||||
| Income Before Taxes | 2,261.1000 | 4,907.6000 | 5,438.1000 | -4,704.3000 | -850.1000 | ||||||
| Income Taxes | -502.4000 | -1,101.4000 | -1,192.2000 | 1,076.7000 | 212.8000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 1,758.7000 | 3,806.2670 | 4,245.9020 | -3,627.5350 | -637.3000 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 457.9000 | 575.3000 | 656.5000 | 194.4000 | 374.9000 | ||||||
| Cash Flow from Investing Activities | -208.8890 | -60.2500 | -784.4380 | -1,207.5930 | 20.2080 | ||||||
| Cash Flow from Financing | -22.7580 | -523.0410 | -55.4290 | 973.5760 | -425.6470 | ||||||
| Decrease / Increase in Cash | 228.4870 | 4.4640 | -195.9820 | -36.5890 | -30.1750 | ||||||
| Employees | 8,120 | - | - | - | - | ||||||
